Greg Timbol
About Greg Timbol
Greg Timbol serves as the National Account Director at DNAnexus, bringing extensive experience in sales and business development within the life sciences and biopharma sectors. He holds a Bachelor of Science in Biochemistry and Molecular Biology from The University of British Columbia and has contributed to various research and development initiatives throughout his career.
Work at DNAnexus
Greg Timbol currently holds the position of National Account Director at DNAnexus, a role he has occupied since 2024. In this capacity, he focuses on strategic account management and business development within the life sciences sector. His responsibilities include leveraging his extensive experience to foster relationships with key stakeholders and drive growth in the biopharmaceutical industry.
Education and Expertise
Greg Timbol earned a Bachelor of Science (BS) degree in Biochemistry and Molecular Biology from The University of British Columbia. His educational background provides a strong foundation for his work in the life sciences and biopharma sectors. He possesses expertise in consultative selling, particularly in AI-enriched data and technology development partnerships.
Background
Greg Timbol has a diverse professional background in sales and business development within the life sciences industry. He has held various leadership positions, including Vice President of Sales & Business Development at Harvest Automation and VP Corporate Sales at Digital Science. His career spans over two decades, with significant experience in managing sales teams and executing market strategies.
Achievements in Sales and Business Development
Throughout his career, Greg Timbol has demonstrated a strong ability to grow and manage sales teams in the life sciences and biopharma sectors. He has successfully led initiatives involving market opportunity assessments and Go-to-Market plans. His previous roles included leading the deployment of autonomous mobile robot teams and engaging in medical affairs for KOL/DOL identification.
Experience in Research and Development
Greg Timbol has contributed to discovery processes related to target identification, validation, and lead optimization of new chemical entities (NCEs). His involvement in translational research for biomarker identification further highlights his commitment to advancing scientific knowledge and innovation in the biopharmaceutical field.